Price
No data yet.
Social Signal Score
Analyst Ratings
5 analystsRevenue
$126.12M+458.24%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Samuel Brill
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 2,300
- Beta
- 1.76
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- -0.15
Financials
Revenue
$126.12M+458.2%Net Income
$-9.81MEBITDA
$25.20M+1472.2%Free Cash Flow
$16.67MEPS (diluted)
$-0.05Shares Outstanding (diluted)
202.73M+20.8%Operating Expenses
$29.68MCash & Debt
$67.00MReturn of Capital
$0.00Revenue by Segment (annual)
$339.56MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $500.58M | $-118.19M | $-0.58 |
| 2024 | $561.60M | $-84.99M | $-0.40 |
| 2023 | $518.59M | $-48.21M | $-0.24 |
| 2022 | $405.93M | $-80.90M | $-0.44 |
| 2021 | $332.38M | $-122.66M | $-0.71 |
| 2020 | $143.73M | $-23.84M | $-0.14 |
| 2019 | $12.03M | $-33.24M | $-0.20 |
| 2018 | $0.00 | $-6.26M | $-0.04 |
Valuation
AAWHhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50-69.39%Social Signal Score
Mentions (4)
- Newsseekingalpha.com·38d ago·Neutral
Ascend Wellness Holdings, Inc. (AAWH) Shareholder/Analyst Call Prepared Remarks Transcript Ascend Wellness Holdings, Inc. (AAWH) Shareholder/Analyst Call Prepared Remarks Transcript
View source ↗ - Newsmarketbeat.com·54d ago·Neutral
Ascend Wellness Q2 Earnings Call Highlights Ascend Wellness OTCMKTS: AAWH reported second-quarter 2026 net revenue of $126.1 million, up 7.9% sequentially, as new dispensary openings and higher retail sales helped offset pricing pressure and competitive conditions in several markets.
View source ↗ - Newszacks.com·54d ago·Neutral
Ascend Wellness Holdings, Inc. (AAWH) Reports Q2 Loss, Beats Revenue Estimates Ascend Wellness Holdings, Inc. (AAWH) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.12 per share a year ago.
View source ↗ - Newsseekingalpha.com·54d ago·Positive
Ascend Wellness Holdings, Inc. (AAWH) Q2 2026 Earnings Call Transcript Ascend Wellness Holdings, Inc. (AAWH) Q2 2026 Earnings Call Transcript
View source ↗
Earnings
Mon, Nov 9(in 5 weeks)
Consensus estimate $-0.07 per share
Typical surprise -15.4% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 12$-0.05 vs $-0.06beat
- Wed, May 13$-0.15 vs $-0.13miss
- Thu, Mar 12$-0.24 vs $-0.12miss
- Mon, Nov 10$-0.13 vs $-0.10miss
- Thu, Aug 7$-0.12 vs $-0.07miss
- Mon, May 12$-0.09 vs $-0.08miss
Estimates and results for AAWH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by AAWH officers and directors.
- Bought
- —
- Sold
- $145k
0 trades
1 trade
- Millstreet Capital Management Llcsold
2 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in AAWH.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.